Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
36,331,098
-
Share change
-
+28,398,421
-
Total reported value
-
$34,891,000
-
Price per share
-
$0.96
-
Number of holders
-
26
-
Value change
-
+$27,280,642
-
Number of buys
-
16
-
Number of sells
-
5
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q1 2017
As of 31 Mar 2017,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,331,098 shares.
The largest 10 holders included
BVF INC/IL, Senvest Management, LLC, SABBY MANAGEMENT, LLC, Alyeska Investment Group, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, ORBIMED ADVISORS LLC, DAFNA Capital Management LLC, MORGAN STANLEY, DEUTSCHE BANK AG\, and Opaleye Management Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.